Guardado en:
| Autor principal: | Bhatti, Tahir |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2025
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.17208972 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Mapping Potential Drug Resistance Mutations in SARS-CoV-2 nsp12 Motifs Q1 2025
por: Tahir, Bhatti
Publicado: (2025)
por: Tahir, Bhatti
Publicado: (2025)
SARS-CoV-2 Spike Mutation Co-occurrence Network - Segment 3: Genomic Surveillance of Co-evolving Mutations in a Global Dataset
por: Tahir, Bhatti
Publicado: (2025)
por: Tahir, Bhatti
Publicado: (2025)
Global Haplotype Landscape of SARS-CoV-2 Spike Contact Residues Reveals Dominant Escape Signatures and Systemic Sequencing Ambiguity
por: Bhatti, Tahir
Publicado: (2025)
por: Bhatti, Tahir
Publicado: (2025)
GVAtlas: Pioneering Genomic Variant Analysis and Visualization for SARS CoV 2 and Beyond
por: Tahir, Bhatti, et al.
Publicado: (2025)
por: Tahir, Bhatti, et al.
Publicado: (2025)
2024 SARS-CoV-2 Sequences with Diagnostic Primer/Probe Mismatch Profiles
por: Bhatti, Tahir
Publicado: (2025)
por: Bhatti, Tahir
Publicado: (2025)
Immunoassay Detection of SARS ‐ CoV ‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
por: Robert M. Hnasko, et al.
Publicado: (2025)
por: Robert M. Hnasko, et al.
Publicado: (2025)
Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS ‐ CoV ‐2 Variants
por: Qianwen Wang, et al.
Publicado: (2025)
por: Qianwen Wang, et al.
Publicado: (2025)
IgG Monoclonal Antibodies: Analytical Perspectives
por: Dhruvi Nilesh Nirmal, et al.
Publicado: (2025)
por: Dhruvi Nilesh Nirmal, et al.
Publicado: (2025)
The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants
por: Shuo Liu, et al.
Publicado: (2025)
por: Shuo Liu, et al.
Publicado: (2025)
Análisis in silico de las alteraciones de la secuencia y estructura de RBD-SARS-CoV-2, que afectan su complementariedad por anticuerpos neutralizantes IgG-antiRBD
por: Ricardo Enrique Grados-Torrez
Publicado: (2023)
por: Ricardo Enrique Grados-Torrez
Publicado: (2023)
Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD
por: Neander, Lenard, et al.
Publicado: (2024)
por: Neander, Lenard, et al.
Publicado: (2024)
Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults
por: Nanyang Li, et al.
Publicado: (2025)
por: Nanyang Li, et al.
Publicado: (2025)
A Chip‐Based Surveillance Platform for Detecting Antibody‐Based Immunity and Immune Escape Using SARS‐CoV‐2 Pseudovirus Surrogates
por: Maisha M. Feroz, et al.
Publicado: (2025)
por: Maisha M. Feroz, et al.
Publicado: (2025)
Developments in the Production of Recombinant Monoclonal Antibodies
por: Debajyoti Saha, et al.
Publicado: (2025)
por: Debajyoti Saha, et al.
Publicado: (2025)
Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
por: Swapna Thomas, et al.
Publicado: (2024)
por: Swapna Thomas, et al.
Publicado: (2024)
Bebtelovimab‐bound SARS‐CoV‐2 RBD mutants: resistance profiling and validation with escape mutations, clinical results, and viral genome sequences
por: Khushboo Bhagat, et al.
Publicado: (2024)
por: Khushboo Bhagat, et al.
Publicado: (2024)
A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2
por: Yakun Sun, et al.
Publicado: (2025)
por: Yakun Sun, et al.
Publicado: (2025)
Genomic Insights Into Respiratory Syncytial Virus Circulation Patterns and Neutralization by Anti‐F Monoclonal Antibodies in Panama (2018–2024)
por: Danilo Franco, et al.
Publicado: (2025)
por: Danilo Franco, et al.
Publicado: (2025)
452ºF
Publicado: (2017)
Publicado: (2017)
Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022
por: Ryan Sandford, et al.
Publicado: (2024)
por: Ryan Sandford, et al.
Publicado: (2024)
Possible rapid reduction of anti‐RBD antibody titre after SARS‐CoV‐2 mRNA vaccination in pregnant women: Multicentre prospective study
por: Mamiko Ohta, et al.
Publicado: (2024)
por: Mamiko Ohta, et al.
Publicado: (2024)
Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
por: Hector F. Pelaez‐Prestel, et al.
Publicado: (2025)
por: Hector F. Pelaez‐Prestel, et al.
Publicado: (2025)
Seroprevalence Trends of Antibodies to SARS‐CoV‐2 in South Korea, 2021–2022: A Repeated Cross‐Sectional Study
por: Ah‐Ra Kim, et al.
Publicado: (2025)
por: Ah‐Ra Kim, et al.
Publicado: (2025)
Design and Implementation of an EWMA Control Chart for Zero‐Inflated Count Data in High‐Quality Processes
por: Muhammad Ali Raza, et al.
Publicado: (2025)
por: Muhammad Ali Raza, et al.
Publicado: (2025)
Adaptabodies: Retargeting a Predefined Monoclonal Antibody With Bispecific Nanobodies for Antibody Therapy
por: Andrés González‐Techera, et al.
Publicado: (2025)
por: Andrés González‐Techera, et al.
Publicado: (2025)
PETRA: Pretrained Evolutionary Transformer for SARS-CoV-2 Mutation Prediction
por: Zou, Xu
Publicado: (2025)
por: Zou, Xu
Publicado: (2025)
Enrichment of G‐to‐U Substitution in SARS‐CoV‐2 Functional Regions and Its Compensation via Concurrent Mutations
por: Xierzhatijiang Sulaiman, et al.
Publicado: (2025)
por: Xierzhatijiang Sulaiman, et al.
Publicado: (2025)
An Asymptotic Analysis of Bivalent Monoclonal Antibody-Antigen Binding
por: Heirene, Luke A, et al.
Publicado: (2025)
por: Heirene, Luke A, et al.
Publicado: (2025)
Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
por: Akram N. Salah, et al.
Publicado: (2025)
por: Akram N. Salah, et al.
Publicado: (2025)
Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology
por: Guillaume Jacquot, et al.
Publicado: (2024)
por: Guillaume Jacquot, et al.
Publicado: (2024)
Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein
por: Aneela Pasha, et al.
Publicado: (2025)
por: Aneela Pasha, et al.
Publicado: (2025)
A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS‐CoV‐2
por: Jun Liu, et al.
Publicado: (2025)
por: Jun Liu, et al.
Publicado: (2025)
Monoclonal Antibody 5F1 Modulates Formyl Peptide Receptor 1 Conformation for Transmembrane Signaling
por: Yue Wang, et al.
Publicado: (2025)
por: Yue Wang, et al.
Publicado: (2025)
Diseños factoriales completos de experimentos para optimizar un ELISA que detecta anticuerpos anti-RBD del SARS-CoV-2 en leche materna
por: Maylin Pérez-Bernal
Publicado: (2023)
por: Maylin Pérez-Bernal
Publicado: (2023)
Stochastic Mutation as a Mechanism for the Emergence of SARS-CoV-2 New Variants
por: Luo, Liaofu, et al.
Publicado: (2025)
por: Luo, Liaofu, et al.
Publicado: (2025)
Quantitative Prediction of Human Pharmacokinetics for Fc‐Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection
por: Kenta Haraya, et al.
Publicado: (2026)
por: Kenta Haraya, et al.
Publicado: (2026)
Fighting Mutations with Mutations: Evolutionarily Adapting a DNA Aptamer for High‐Affinity Recognition of Mutated Spike Proteins of SARS‐CoV‐2
por: Qing Wang, et al.
Publicado: (2024)
por: Qing Wang, et al.
Publicado: (2024)
Self‐Driving Development of Perfusion Processes for Monoclonal Antibody Production
por: Chethana Janardhana Gadiyar, et al.
Publicado: (2025)
por: Chethana Janardhana Gadiyar, et al.
Publicado: (2025)
Rapid Purification Strategies for Monoclonal Antibodies: A Case Study
por: Qian Li, et al.
Publicado: (2025)
por: Qian Li, et al.
Publicado: (2025)
Generation of Conformation‐Specific Monoclonal Antibodies for Integral Membrane Proteins
por: Natalie Sheldon, et al.
Publicado: (2025)
por: Natalie Sheldon, et al.
Publicado: (2025)
Ejemplares similares
-
Mapping Potential Drug Resistance Mutations in SARS-CoV-2 nsp12 Motifs Q1 2025
por: Tahir, Bhatti
Publicado: (2025) -
SARS-CoV-2 Spike Mutation Co-occurrence Network - Segment 3: Genomic Surveillance of Co-evolving Mutations in a Global Dataset
por: Tahir, Bhatti
Publicado: (2025) -
Global Haplotype Landscape of SARS-CoV-2 Spike Contact Residues Reveals Dominant Escape Signatures and Systemic Sequencing Ambiguity
por: Bhatti, Tahir
Publicado: (2025) -
GVAtlas: Pioneering Genomic Variant Analysis and Visualization for SARS CoV 2 and Beyond
por: Tahir, Bhatti, et al.
Publicado: (2025) -
2024 SARS-CoV-2 Sequences with Diagnostic Primer/Probe Mismatch Profiles
por: Bhatti, Tahir
Publicado: (2025)